Johnson & Johnson reported a slightly better-than-expected quarterly profit as surging sales of new drugs and mainstay older brands offset weak demand for medical devices and consumer healthcare products.
The world's biggest drugmakers face a new reality when it comes to U.S. pricing for their products as insurers use aggressive tactics to extract steep price discounts, even for the newest medications.
Of every $10 spent on healthcare in the U.S., almost 90 cents is due to smoking, a new analysis says. Using recent health and medical spending surveys, researchers calculated that 8.7 percent of all healthcare spending, or $170 billion a year, is for illness caused by tobacco smoke, and public programs like Medicare and Medicaid paid for most of these costs.
Security researchers say they have uncovered a cyber espionage ring focused on stealing corporate secrets for the purpose of gaming the stock market, in an operation that has compromised sensitive data about dozens of publicly held companies.
Leading U.S. CEOs, angered by the Obama administration's challenge to certain "workplace wellness" programs, are threatening to side with anti-Obamacare forces unless the government backs off, according to people familiar with the matter.
Britain's biggest drugmaker, GlaxoSmithKline Plc, fired an executive from its South African unit for refusing to appear for a performance review, which was called a week after he complained of racial discrimination in the workplace, Bloomberg reported, citing company documents.
India's economy will accelerate in 2015 but will fail to attain the heady growth rates of the past decade without sweeping structural reforms, the Organisation for Economic Cooperation and Development said on Wednesday.
Japan's Fujifilm Holdings Corp said it was difficult to estimate the profitability of its influenza drug Avigan, which has been earmarked to fight Ebola, given the uncertainty over the spread of virus, a company executive said on Thursday.
French economist Jean Tirole won the 2014 Nobel Prize for economics for work that has shed light on how governments can "tame" the big businesses that dominate once-public monopolies like railways, highways and telecommunications.
Medical equipment supplier Becton Dickinson & Co (BDX.N) has agreed to buy CareFusion Corp (CFN.N), a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar healthcare sector deal.
U.S. employers ramped up hiring in September and the jobless rate fell to a six-year low, bolstering bets the Federal Reserve will hike interest rates in mid-2015.
High salaries and free food aren't enough any more in Silicon Valley, where maturing companies are competing for talent with creative health care and "wellness" programs that use gadgets to promote good behavior.
A positive vibe returned to the U.S. stock market Friday, leaving some to wonder if, after two weeks of losses, the latest selloff scare was over. The best clues may come from what happens to low-quality corporate bonds.
The S&P 500 posted its best day since August on Friday following a stronger-than-expected September U.S. jobs report that bolstered the outlook for the U.S. economy.
Specialty healthcare company Endo International Plc (ENDP.O) (ENL.TO) offered to buy Auxilium Pharmaceuticals Inc (AUXL.O) for about $2.2 billion in cash and stock to expand its men's healthcare products business.